Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Atopic dermatitis].

C Beylot1

  • 1Service de dermatologie Hôpital du Haut-Lévêque CHU de Bordeaux 33604 Pessac.

La Revue Du Praticien
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Atopic dermatitis (eczema) is rising in North Europe, affecting 15% of children. Avoiding triggers like allergens may reduce incidence and severity, offering hope beyond topical steroids.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Skin ageing-General features of facial ageing and therapeutic choices].

Annales de dermatologie et de venereologie·2018
Same author

[Post-inflammatory hyperpigmentation occuring after cosmetic procedures].

Annales de dermatologie et de venereologie·2018
Same author

Propionibacterium acnes: an update on its role in the pathogenesis of acne.

Journal of the European Academy of Dermatology and Venereology : JEADV·2013
Same author

Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe.

Journal of the European Academy of Dermatology and Venereology : JEADV·2010
Same author

[Ablative and fractional lasers].

Annales de dermatologie et de venereologie·2009
Same author

[Legal guidelines in esthetic dermatology].

Annales de dermatologie et de venereologie·2009
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
Same journal

[Summary Ischemic stroke in children].

La Revue du praticien·2026
Same journal

[Treatment type 1 diabetes in children].

La Revue du praticien·2026
Same journal

[Diagnostic and therapeutic strategies for small-bowel gastrointestinal bleeding when initial upper endoscopy and colonoscopy are unremarkable].

La Revue du praticien·2026
Same journal

[Non-portal hypertension-related upper gastrointestinal bleeding].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Dermatology
  • Pediatrics
  • Allergology

Background:

  • Atopic dermatitis (eczema) prevalence has increased globally, particularly in North Europe.
  • Affects up to 15% of children aged 0-7 years, with a rise in associated respiratory disorders like asthma.
  • Current research focuses on genetic and environmental interactions, including allergens and maternal smoking.

Purpose of the Study:

  • To review current understanding of atopic dermatitis (eczema) triggers and management.
  • To explore the potential of trigger avoidance in preventing or reducing disease severity.
  • To highlight emerging immunomodulatory treatment possibilities for severe cases.

Main Methods:

  • Literature review of recent studies on atopic dermatitis pathogenesis.

Related Experiment Videos

  • Analysis of environmental factors contributing to disease development.
  • Evaluation of current and potential therapeutic strategies.

    • Main Results:

    • Genetic and environmental factors, such as house dust mites and food allergens, play a key role.
    • Maternal and infant avoidance of specific triggers may decrease atopic dermatitis incidence and severity.
    • Topical steroids remain the standard symptomatic treatment, but new immunomodulatory options are emerging.

    Conclusions:

    • Understanding atopic dermatitis pathogenesis is crucial for developing targeted therapies.
    • Preventive strategies involving trigger avoidance show promise for susceptible populations.
    • Immunomodulatory treatments offer hope for managing refractory atopic dermatitis cases.